Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.70 |
| ▸ | CES2 | O00748 | 1/20 | 0.69 |
| ▸ | CES1 | P23141 | 1/20 | 0.69 |
| ▸ | ESR1 | P03372 | 1/20 | 0.63 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.58 |
| ▸ | TP53 | P04637 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 9/20 | 0.57 |
| ▸ | RAB9A | P51151 | 8/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.55 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.55 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.55 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.54 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30393680 | 0.86 | CES2 (0.71) | PARP1CES2CES1ESR1ESR2 | |
| Methyl 3-Methoxybenzoate SCHEMBL384913 | 0.86 | SMN1; SMN2 (0.73) | PARP1CES2CES1ESR1ESR2 | |
| SCHEMBL447346 | 0.86 | CES2 (0.71) | PARP1CES2CES1ESR1ESR2 | |
| Methyl 3-Methoxybenzoate SCHEMBL29702092 | 0.86 | SMN1; SMN2 (0.73) | PARP1CES2CES1ESR1ESR2 | |
| SCHEMBL23509 | 0.86 | CES2 (0.71) | PARP1CES2CES1ESR1ESR2 | |
| SCHEMBL8190990 | 0.83 | CES2 (0.67) | PARP1CES2CES1ESR1ESR2 | |
| SCHEMBL28120515 | 0.83 | CES2 (0.67) | PARP1CES2CES1ESR1ESR2 | |
| SCHEMBL17629345 | 0.83 | PARP1 (0.68) | PARP1CES2CES1ESR1ESR2 | |
| SCHEMBL27616751 | 0.83 | CES2 (0.67) | PARP1CES2CES1ESR1ESR2 | |
| SCHEMBL6970519 | 0.83 | CES2 (0.67) | PARP1CES2CES1ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0484265-A1 | A process for the preparation of omeprazol | CENTRO GENESIS PARA LA INVESTIGACION, S.L. (ES) | 1992-05-06 | — | — | EP | claimed |
| WO-2024033288-A1 | SALICIN DERIVATIVES AS INHIBITORS OF SGLT2 | Société des Produits Nestlé S.A. (CH) | 2024-02-15 | — | — | WO | disclosed |
| WO-2022177313-A1 | SESQUITERPENE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND USE THEREOF | 엠에프씨 주식회사 | 2022-08-25 | — | — | WO | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| US-9431172-B2 | Biaxially oriented electrical insulating film | BOREALIS TECHNOLOGY OY (FI) | 2016-08-30 | — | — | US | disclosed |
| CN-102762260-A | Oral compositions containing extracts of zizyphus joazeiro and related methods | COLGATE PALMOLIVE CO | 2012-10-31 | — | — | CN | disclosed |
| CN-102665674-A | Oral compositions containing a combination of natural extracts and related methods | COLGATE PALMOLIVE CO | 2012-09-12 | — | — | CN | disclosed |
| EP-2440632-A2 | LIQUID CRYSTAL COMPOSITIONS | E. I. du Pont de Nemours and Company (US) | 2012-04-18 | — | — | EP | disclosed |
| EP-2440631-A1 | LIQUID CRYSTAL COMPOSITIONS | E. I. du Pont de Nemours and Company (US) | 2012-04-18 | — | — | EP | disclosed |
| US-20110280940-A1 | Di-Vanilloyl And Tri-Vanilloyl Derivatives For Use In Anti-Cancer Therapy | KISS ROBERT (BE) | 2011-11-17 | — | — | US | disclosed |
| EP-0879830-B1 | Modified polypropylene having improved processability | BOREALIS GMBH (AT) | 2002-11-13 | — | — | EP | disclosed |
| EP-1247837-A2 | Modified amino resins for semifinished products and molded bodies having an improved resilience | Agrolinz Melamin GmbH (AT) | 2002-10-09 | — | — | EP | disclosed |
| EP-0884355-B1 | Polyolefin foams with fine cells | BOREALIS GMBH (AT) | 2002-07-17 | — | — | EP | disclosed |
| EP-0884355-A1 | Polyolefin foams with fine cells | PCD Polymere AG (AT) | 1998-12-16 | — | — | EP | disclosed |
| EP-0884335-A1 | Segmented polyolefines | PCD Polymere AG (AT) | 1998-12-16 | — | — | EP | disclosed |
| EP-0879844-A1 | Polyolefin foams with high resistance against deformation by heat | PCD Polymere AG (AT) | 1998-11-25 | — | — | EP | disclosed |
| EP-0879830-A1 | Modified polypropylene having improved processability | PCD Polymere AG (AT) | 1998-11-25 | — | — | EP | disclosed |
| EP-0878567-A2 | Polyolefin fibres and polyolefin yarns and textile materials thereof | PCD Polymere AG (AT) | 1998-11-18 | — | — | EP | disclosed |
| EP-0821018-A2 | Crosslinkable olefinic polymers and method for their preparation | PCD-Polymere Gesellschaft m.b.H. (AT) | 1998-01-28 | — | — | EP | disclosed |
| EP-0787750-A2 | Poly(alkylethylene) structural isomers | PCD-Polymere Gesellschaft m.b.H. (AT) | 1997-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110280940-A1 | Di-Vanilloyl And Tri-Vanilloyl Derivatives For Use In Anti-Cancer Therapy | PSEN2, PSEN1, VHL | PARP1 218/4885CES2 2470/4885CES1 3812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.